Cleistanthus bracteosus
Cleistanthus bracteosus · Accepted scientific name
Scientific literature: Very Sparse (0 studies) · ★☆☆☆☆
Cleistanthus bracteosus is a notable plant species that has garnered significant scientific interest due to its unique chemical profile. The plant contains valuable bioactive compounds, including cedrene, cedrol, and digoxigenin. Research into these constituents suggests that the plant may play a role in combating various viral threats. Specifically, studies have investigated its potential effectiveness against pathogens such as Human Metapneumovirus and Nipah virus. Understanding these medicinal properties offers promising insights for future pharmacological developments.
- Synonyms
- Not available
- Common names
- Not available
- Family
- Phyllanthaceae
- Distribution
- Southern America
- Plant Parts
- Not available
Classification
Taxonomy
Cleistanthus bracteosus is a unique botanical specimen that belongs to the kingdom Plantae. Within this vast kingdom, the plant is classified under the class Equisetopsida. It further belongs to the order Malpighiales, showcasing its specific evolutionary lineage. As a member of the family Phyllanthaceae, it shares structural characteristics with many related species. Finally, this plant is identified by its distinct genus, Cleistanthus.
| Rank | Classification |
|---|---|
| Kingdom | Plantae |
| Phylum | Streptophyta |
| Class | Equisetopsida |
| Subclass | Magnoliidae |
| Order | Malpighiales |
| Family | Phyllanthaceae |
| Genus | Cleistanthus |
Sources: The World Checklist of Vascular Plants (WCVP)
Distribution
Geographic Regions
Cleistanthus bracteosus is a notable plant species primarily found within the tropical regions of Asia. Its natural distribution is centered in the Malesia zone, where it thrives in specific environmental conditions. Within this vast geographical range, the species is particularly well-documented throughout the landscapes of Malaya. This specific habitat allows the plant to play its unique role within the local tropical ecosystems. Understanding its regional presence provides valuable insight into the botanical diversity of Southeast Asian forests.
Sources: The World Checklist of Vascular Plants (WCVP)
Identification
Morphology
Cleistanthus bracteosus is a tree characterized by its distinct growth form. This species is entirely self-supporting, standing firmly on its own within its natural habitat.
Sources: Global Inventory of Floras and Traits (GIFT)
Biological Activities
Compounds
Cleistanthus bracteosus contains several noteworthy phytochemicals that have recently been investigated for their significant therapeutic potential. Specifically, this plant contains cedrene and cedrol, both of which are essential components identified through GC-MS analysis. Furthermore, Cleistanthus bracteosus contains digoxigenin, a compound that contributes to the plant's complex chemical profile. In recent in-silico studies, these three specific compounds demonstrated remarkable binding affinities against the glycoproteins of the Nipah virus and human metapneumovirus. This research suggests that the chemical constituents found within C. bracteosus could serve as a novel foundation for developing antiviral therapeutic strategies.
Conditions
Cleistanthus bracteosus contains phytochemicals that demonstrate significant predicted antiviral potential against both Nipah virus and human metapneumovirus. Through AI-driven in-silico studies, specific compounds from this plant were shown to target essential glycoproteins required for viral pathogenesis. For instance, compounds such as digoxigenin exhibited strong binding affinities with the Nipah virus fusion and attachment glycoproteins. Additionally, these same phytochemicals displayed remarkable binding interactions with the human metapneumovirus fusion glycoprotein. These computational findings suggest that the major compounds in Cleistanthus bracteosus could serve as a novel therapeutic strategy to control the entry and progression of these viruses.